THE SCIENCE
Chronic joint pain starts at the cellular level. As damaged cells build up, they release signals that fuel inflammation, weaken cartilage, and speed breakdown. Restoring the body’s natural cleanup process, known as autophagy, and calming these root causes of inflammation can ease pain and restore joint strength.
How inflammation impacts healthspan

Interventions can help
Rebalance inflammatory cascades
Chronic inflammation inside the joint accelerates tissue breakdown and worsens pain. By targeting the pathways that drive inflammation, therapies like low-dose naltrexone and rapamycin help calm signals, protect cartilage, and reduce discomfort.



Enhance Autophagy Pathways
Your body has natural cleanup systems that clear damaged proteins and waste from joint tissue. When these processes slow, damage accumulates and pain worsens. Therapies such as rapamycin can reactivate autophagy, restoring cartilage integrity and
Reduce Senescence in the Joint
Aged, dysfunctional cells accumulate in joint tissues and release inflammatory signals that harm healthy cartilage. Therapies such as rapamycin help target senescence, lowering inflammation and restoring the joint’s ability to regenerate.

Enhance Autophagy Pathways
Your body has natural cleanup systems that clear damaged proteins and waste from joint tissue. When these processes slow, damage accumulates and pain worsens. Therapies such as rapamycin can reactivate autophagy, restoring cartilage integrity and

Rebalance inflammatory cascades
Chronic inflammation inside the joint accelerates tissue breakdown and worsens pain. By targeting the pathways that drive inflammation, therapies like low-dose naltrexone and rapamycin help calm signals, protect cartilage, and reduce discomfort.

Reduce Senescence in the Joint
Aged, dysfunctional cells accumulate in joint tissues and release inflammatory signals that harm healthy cartilage. Therapies such as rapamycin help target senescence, lowering inflammation and restoring the joint’s ability to regenerate.
Hear from our patients
(Featured In)
(Featured In)
Ahead of the field
“I'd say 90% range of motion was back, and the pain was probably 90% gone — and it hasn't come back.”
“It seems to delay decline in multiple organ systems...a sign of fundamentally slowing aging.”
“I would say that rapamycin is the current best-in-class for a longevity drug that we have.”
“Decades of research show mTOR and rapamycin remain the gold standard for targeting aging biology.”
“This exotic molecule acts like a switch, blocking a cellular mechanism shared by nearly all life.”
“The drug reduces growth cues, prompting cells to clear debris and improve performance.”
“I'd say 90% range of motion was back, and the pain was probably 90% gone — and it hasn't come back.”
“It seems to delay decline in multiple organ systems...a sign of fundamentally slowing aging.”
“I would say that rapamycin is the current best-in-class for a longevity drug that we have.”
“Decades of research show mTOR and rapamycin remain the gold standard for targeting aging biology.”
“This exotic molecule acts like a switch, blocking a cellular mechanism shared by nearly all life.”
“The drug reduces growth cues, prompting cells to clear debris and improve performance.”
“I'd say 90% range of motion was back, and the pain was probably 90% gone — and it hasn't come back.”
“It seems to delay decline in multiple organ systems...a sign of fundamentally slowing aging.”
“I would say that rapamycin is the current best-in-class for a longevity drug that we have.”
“Decades of research show mTOR and rapamycin remain the gold standard for targeting aging biology.”
“This exotic molecule acts like a switch, blocking a cellular mechanism shared by nearly all life.”
“The drug reduces growth cues, prompting cells to clear debris and improve performance.”
“I'd say 90% range of motion was back, and the pain was probably 90% gone — and it hasn't come back.”
“It seems to delay decline in multiple organ systems...a sign of fundamentally slowing aging.”
“I would say that rapamycin is the current best-in-class for a longevity drug that we have.”
“Decades of research show mTOR and rapamycin remain the gold standard for targeting aging biology.”
“This exotic molecule acts like a switch, blocking a cellular mechanism shared by nearly all life.”
“The drug reduces growth cues, prompting cells to clear debris and improve performance.”
Reviews
127 reviews
We study the studies
Healthspan longevity experts continuously review the latest clinical research, curating results to help deepen your understanding of aging science.